Pharmacists’ Shifting Meeting Preferences

We have begun analyzing our preliminary 2023 Integrated Delivery Network (IDN) survey data and have found that oncology pharmacists are once again looking forward to meeting manufacturer team members in person. Our 2022 research found providers still grappling with COVID-19 impacts and preferring virtual meetings. Now, with a better understanding of COVID and its effects, providers’ preferences are shifting toward in-person interactions, although virtual options remain in the mix. 

Source: HMP Market Access Insights.
Abbreviations: HCP, health care professional.

We are now conducting our follow-up interviews, and beyond the survey findings the oncology pharmacists tell us:

• Independent web and health care professional site searches remain their most flexible option to obtain clinical or drug administration information.
• Virtual meetings with pharmaceutical personnel provide efficient interactions that are more accommodating for clinic schedules.
• In-person meetings (on site or at conferences) offer greater opportunities for the pharmacy staff/team to build relationships with manufacturer personnel and experience interactive learning sessions.

Stay tuned for more insights and the publication of our 2023 IDN Oncology Trend Survey next month.  Until then, please reach out with any comments or questions you may have.